DCP1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.842000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.677800E-01
Normal-vs-Stage2
7.048000E-01
Normal-vs-Stage3
1.111370E-01
Normal-vs-Stage4
4.525400E-01
Stage1-vs-Stage2
4.599400E-01
Stage1-vs-Stage3
1.465440E-01
Stage1-vs-Stage4
5.316800E-01
Stage2-vs-Stage3
3.733800E-01
Stage2-vs-Stage4
9.710800E-01
Stage3-vs-Stage4
1.938570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.331000E-01
Normal-vs-AfricanAmerican
4.005800E-01
Normal-vs-Asian
1.359170E-01
Caucasian-vs-AfricanAmerican
6.490200E-01
Caucasian-vs-Asian
5.289600E-02
AfricanAmerican-vs-Asian
2.371200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.982600E-01
Normal-vs-Female
5.316600E-01
Male-vs-Female
2.866000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.740600E-01
Normal-vs-Age(41-60Yrs)
7.627800E-01
Normal-vs-Age(61-80Yrs)
7.909000E-01
Normal-vs-Age(81-100Yrs)
3.853000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.268600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.523200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.996200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.320000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.317800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.842600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.646200E-01
Normal-vs-Daily Drinker
5.691000E-01
Normal-vs-Weekly Drinker
8.286400E-02
Normal-vs-Occasional Drinker
8.042800E-01
Normal-vs-Social Drinker
9.575400E-01
Non Drinker-vs-Daily Drinker
6.573800E-01
Non Drinker-vs-Weekly Drinker
4.805200E-01
Non Drinker-vs-Occasional Drinker
6.078100E-02
Non Drinker-vs-Social Drinker
1.450030E-01
Daily Drinker-vs-Weekly Drinker
2.416400E-01
Daily Drinker-vs-Occasional Drinker
1.424590E-01
Daily Drinker-vs-Social Drinker
2.791000E-01
Weekly Drinker-vs-Occasional Drinker
1.577700E-02
Weekly Drinker-vs-Social Drinker
3.795700E-02
Occasional Drinker-vs-Social Drinker
7.175600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.216000E-01
Normal-vs-Grade 2
1.042610E-01
Normal-vs-Grade 3
1.719910E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.041760E-01
Grade 1-vs-Grade 3
9.076000E-02
Grade 1-vs-Grade 4
2.216000E-01
Grade 2-vs-Grade 3
8.698400E-01
Grade 2-vs-Grade 4
1.042610E-01
Grade 3-vs-Grade 4
1.719910E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.372600E-01
Normal-vs-NonDiabetic
7.758800E-01
Diabetic-vs-NonDiabetic
3.652400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.500800E-01
Normal-vs-NoPancreatitis
6.917600E-01
Pancreatitis-vs-NoPancreatitis
9.285400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.560000E-01
Normal-vs-N1
6.983800E-01
N0-vs-N1
4.990000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.398800E-01
Normal-vs-TP53-NonMutant
7.978600E-01
TP53-Mutant-vs-TP53-NonMutant
1.206970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
